Objective:To explore the effect of“Jianpi Tongwei Prescription”acupoint application combined with moxibustion in the treatment of gastric retention in elderly patients with nasal feeding.Method:60 cases elderly pati...Objective:To explore the effect of“Jianpi Tongwei Prescription”acupoint application combined with moxibustion in the treatment of gastric retention in elderly patients with nasal feeding.Method:60 cases elderly patients with nasogastric gastric retention in our hospital were selected as the research object from March 1,2019 to on October 31,2019,and were randomly divided into treatment group and control group.Patients in the control group received the nasal feeding of domperidone,10 mg/time,3 times/d,for 21 days or until gastric retention<100 mL.On the basis of the control group,patients in the treatment group was treated with traditional Chinese medicine(TCM)characteristic nursing“Jianpi Tongwei Prescription”acupoint application combined with moxibustion on Zusanli.Results:The effective rate of Jianpi Tongwei Prescription combined with moxibustion in the treatment of gastric retention in elderly patients with nasal feeding was higher than that of conventional treatment(51.2%vs.23.3%,P<0.05),and the rate of gastrointestinal reaction in the treatment group was significantly lower than that in the control group(P<0.05),moderate and severe gastrointestinal reactions were significantly lower than the control group(P<0.05).Conclusion:“Jianpi Tongwei Prescription”acupoint application combined with moxibustion is effective in the treatment of early clinical symptoms of gastric retention in elderly patients with nasal feeding,no adverse reactions,worthy of clinical promotion and application.展开更多
背景如何保证呼吸科重症监护室(intensive care unit,ICU)患者肠内营养治疗安全性及有效性成为研究热点.胃残余量为肠内营养重要评估指标,可指导后续干预但近年来临床对胃残余量的评估准确性、科学性存在一定争议.目的探讨腹内压联合24 ...背景如何保证呼吸科重症监护室(intensive care unit,ICU)患者肠内营养治疗安全性及有效性成为研究热点.胃残余量为肠内营养重要评估指标,可指导后续干预但近年来临床对胃残余量的评估准确性、科学性存在一定争议.目的探讨腹内压联合24 h胃残余量监测调适的肠内营养方案在呼吸科ICU鼻饲患者中的应用效果.方法选取2019-02/2020-12我院呼吸科ICU鼻饲患者82例,依据随机数字表法分为研究组(n=41)及对照组(n=41).对照组采取常规营养支持,研究组采取腹内压联合24 h胃残余量监测调适的肠内营养方案干预.统计两组治疗情况、干预前后营养状态指标[转铁蛋白(transferrin,TF)、前白蛋白(prealbumin,PA)、白蛋白(albumin,ALB)]水平、T细胞亚群指标(CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+))水平、不良事件发生情况.结果(1)研究组达目标喂养用时、ICU住院时间短于对照组(P<0.05);(2)干预后两组TF、PA、ALB水平较干预前增高(P<0.05),但研究组干预后TF、PA、ALB水平虽略高于对照组,但二者比较无显著差异;(3)两组CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)干预后水平增高(P<0.05),但研究组干预后CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)水平虽略高于对照组,但二者比较无显著差异;(4)研究组营养达标率较对照组高,营养支持中断发生率较对照组低(P<0.05);(5)研究组腹胀、呕吐的发生率(4.88%)明显低于对照组(21.95%)(P<0.05).但两组吸入性肺炎及腹泻的发生率比较无显著差异.结论腹内压联合24 h胃残余量监测调适的肠内营养方案在呼吸科ICU鼻饲患者中具有较高应用价值,可改善患者机体营养状态及免疫功能,提高生存质量,减少不良事件发生.展开更多
文摘Objective:To explore the effect of“Jianpi Tongwei Prescription”acupoint application combined with moxibustion in the treatment of gastric retention in elderly patients with nasal feeding.Method:60 cases elderly patients with nasogastric gastric retention in our hospital were selected as the research object from March 1,2019 to on October 31,2019,and were randomly divided into treatment group and control group.Patients in the control group received the nasal feeding of domperidone,10 mg/time,3 times/d,for 21 days or until gastric retention<100 mL.On the basis of the control group,patients in the treatment group was treated with traditional Chinese medicine(TCM)characteristic nursing“Jianpi Tongwei Prescription”acupoint application combined with moxibustion on Zusanli.Results:The effective rate of Jianpi Tongwei Prescription combined with moxibustion in the treatment of gastric retention in elderly patients with nasal feeding was higher than that of conventional treatment(51.2%vs.23.3%,P<0.05),and the rate of gastrointestinal reaction in the treatment group was significantly lower than that in the control group(P<0.05),moderate and severe gastrointestinal reactions were significantly lower than the control group(P<0.05).Conclusion:“Jianpi Tongwei Prescription”acupoint application combined with moxibustion is effective in the treatment of early clinical symptoms of gastric retention in elderly patients with nasal feeding,no adverse reactions,worthy of clinical promotion and application.